Poly(ADP-ribose) Polymerase Inhibitors

All categories
DBCAT001523Therapeutic category

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. A DrugBank category of 12 drugs. 5 of them are approved.

Also known as
Inhibitors of Poly(ADP-ribose) Polymerases · Inhibitors, PARP · PARP Inhibitors · Poly(ADP-ribosylation) Inhibitors
Drugs

What you can answer from here — as of August 24, 2016

12DrugsEach linked to its full drug card
Listed above
7Drug targetsEvery drug–target pair in the class, with bond type
Sign in
149Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Poly(ADP-ribose) Polymerase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In